262 related articles for article (PubMed ID: 30240186)
1. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract][Full Text] [Related]
2. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEMBL Data for Antiretroviral Compounds.
Vásquez-Domínguez E; Armijos-Jaramillo VD; Tejera E; González-Díaz H
Mol Pharm; 2019 Oct; 16(10):4200-4212. PubMed ID: 31426639
[TBL] [Abstract][Full Text] [Related]
3. PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; Montemore MM; González-Díaz H
Mol Pharm; 2020 Jul; 17(7):2612-2627. PubMed ID: 32459098
[TBL] [Abstract][Full Text] [Related]
4. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
[TBL] [Abstract][Full Text] [Related]
5. PTML Model of ChEMBL Compounds Assays for Vitamin Derivatives.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva Caracuel E; González-Díaz H
ACS Comb Sci; 2020 Mar; 22(3):129-141. PubMed ID: 32011854
[TBL] [Abstract][Full Text] [Related]
6. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
[TBL] [Abstract][Full Text] [Related]
7. Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2019 Nov; 11(45):21811-21823. PubMed ID: 31691701
[TBL] [Abstract][Full Text] [Related]
8. Perturbation-Theory Machine Learning (PTML) Multilabel Model of the ChEMBL Dataset of Preclinical Assays for Antisarcoma Compounds.
Cabrera-Andrade A; López-Cortés A; Munteanu CR; Pazos A; Pérez-Castillo Y; Tejera E; Arrasate S; González-Díaz H
ACS Omega; 2020 Oct; 5(42):27211-27220. PubMed ID: 33134682
[TBL] [Abstract][Full Text] [Related]
9. Perturbation-Theory and Machine Learning (PTML) Model for High-Throughput Screening of Parham Reactions: Experimental and Theoretical Studies.
Simón-Vidal L; García-Calvo O; Oteo U; Arrasate S; Lete E; Sotomayor N; González-Díaz H
J Chem Inf Model; 2018 Jul; 58(7):1384-1396. PubMed ID: 29898360
[TBL] [Abstract][Full Text] [Related]
10. IFPTML Mapping of Drug Graphs with Protein and Chromosome Structural Networks vs. Pre-Clinical Assay Information for Discovery of Antimalarial Compounds.
Quevedo-Tumailli V; Ortega-Tenezaca B; González-Díaz H
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884870
[TBL] [Abstract][Full Text] [Related]
11. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
[TBL] [Abstract][Full Text] [Related]
12. General theory for multiple input-output perturbations in complex molecular systems. 1. Linear QSPR electronegativity models in physical, organic, and medicinal chemistry.
González-Díaz H; Arrasate S; Gómez-SanJuan A; Sotomayor N; Lete E; Besada-Porto L; Ruso JM
Curr Top Med Chem; 2013; 13(14):1713-41. PubMed ID: 23889050
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML).
Sampaio-Dias IE; Rodríguez-Borges JE; Yáñez-Pérez V; Arrasate S; Llorente J; Brea JM; Bediaga H; Viña D; Loza MI; Caamaño O; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2021 Jan; 12(1):203-215. PubMed ID: 33347281
[TBL] [Abstract][Full Text] [Related]
14. Machine Learning and Perturbation Theory Machine Learning (PTML) in Medicinal Chemistry, Biotechnology, and Nanotechnology.
Herrera-Ibatá DM
Curr Top Med Chem; 2021; 21(7):649-660. PubMed ID: 33475073
[TBL] [Abstract][Full Text] [Related]
15. Multi-target Drug Discovery via PTML Modeling: Applications to the Design of Virtual Dual Inhibitors of CDK4 and HER2.
Kleandrova VV; Scotti MT; Scotti L; Speck-Planche A
Curr Top Med Chem; 2021; 21(7):661-675. PubMed ID: 33463472
[TBL] [Abstract][Full Text] [Related]
16. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of U.S. counties.
Herrera-Ibatá DM; Pazos A; Orbegozo-Medina RA; Romero-Durán FJ; González-Díaz H
Biosystems; 2015 Jun; 132-133():20-34. PubMed ID: 25916548
[TBL] [Abstract][Full Text] [Related]
17. Prediction of Anti-Glioblastoma Drug-Decorated Nanoparticle Delivery Systems Using Molecular Descriptors and Machine Learning.
Munteanu CR; Gutiérrez-Asorey P; Blanes-Rodríguez M; Hidalgo-Delgado I; Blanco Liverio MJ; Castiñeiras Galdo B; Porto-Pazos AB; Gestal M; Arrasate S; González-Díaz H
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768951
[TBL] [Abstract][Full Text] [Related]
18. Predicting Metabolic Reaction Networks with Perturbation-Theory Machine Learning (PTML) Models.
Diéguez-Santana K; Casañola-Martin GM; Green JR; Rasulev B; González-Díaz H
Curr Top Med Chem; 2021; 21(9):819-827. PubMed ID: 33797370
[TBL] [Abstract][Full Text] [Related]
19. NL MIND-BEST: a web server for ligands and proteins discovery--theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum.
González-Díaz H; Prado-Prado F; Sobarzo-Sánchez E; Haddad M; Maurel Chevalley S; Valentin A; Quetin-Leclercq J; Dea-Ayuela MA; Teresa Gomez-Muños M; Munteanu CR; José Torres-Labandeira J; García-Mera X; Tapia RA; Ubeira FM
J Theor Biol; 2011 May; 276(1):229-49. PubMed ID: 21277861
[TBL] [Abstract][Full Text] [Related]
20. Modeling Antibacterial Activity with Machine Learning and Fusion of Chemical Structure Information with Microorganism Metabolic Networks.
Nocedo-Mena D; Cornelio C; Camacho-Corona MDR; Garza-González E; Waksman de Torres N; Arrasate S; Sotomayor N; Lete E; González-Díaz H
J Chem Inf Model; 2019 Mar; 59(3):1109-1120. PubMed ID: 30802402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
